Giedrius Gasiūnas

home / authors / giedrius-gasi-nas

Giedrius Gasiūnas, PhD, is chief scientific officer at Caszyme.

Articles

Genetic engineering, GMO and Gene manipulation, DNA gene editing, CRISPR-Cas9 gene editing tool | Image Source: © catalin -stock.adobe.com

CRISPR Gene-Editing Technology in the Development of Biopharmaceuticals

Laima Trinkūnienė;Giedrius Gasiūnas;Monika Paulė

June 9th 2025

Novel nucleases with diverse properties represent promising solutions, emphasizing their potential to overcome current limitations in genome editing and therapeutic delivery.

Latest Updated Articles

Published: October 11th 2024 | Updated: March 3rd 2025

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 11th 2024 | Updated: September 18th 2024

CPHI Pharma Award Finalists Announced for 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Published: March 27th 2024 | Updated: June 28th 2024

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

Published: July 20th 2020 | Updated: June 30th 2025

Contact BioPharm International Editors

Published: June 19th 2025 | Updated: June 30th 2025

BIO 2025: Building Relationships Amid a Rebrand

PCI Pharma Services office in Mississauga, Ontario, Canada on September 19, 2020. PCI is an expert in pharmaceutical and biopharmaceutical supply chain solutions. | Image Credit: © JHVEPhoto - stock.adobe.com

Published: June 5th 2025 | Updated: June 30th 2025

PCI Pharma Services Introduces New Manufacturing Facility Ahead of BIO 2025

About Us

Advertise

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777